OMX Nordic 40
|
2 381,71
|
25,36
|
1,08 %
|
Analysen zu OMX Nordic 40-Werten
| 09.07.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 09.07.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.07.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.07.25 | ABB Neutral | UBS AG | |
| 08.07.25 | Hennes & Mauritz AB Neutral | UBS AG | |
| 04.07.25 | AstraZeneca Buy | UBS AG | |
| 04.07.25 | Volvo AB Outperform | RBC Capital Markets | |
| 04.07.25 | ABB Sector Perform | RBC Capital Markets | |
| 03.07.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.07.25 | Nokia Underweight | Barclays Capital | |
| 03.07.25 | Nokia Market-Perform | Bernstein Research | |
| 03.07.25 | Novo Nordisk Buy | UBS AG | |
| 02.07.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 02.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.07.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 01.07.25 | Novo Nordisk Buy | UBS AG | |
| 01.07.25 | AstraZeneca Buy | UBS AG | |
| 30.06.25 | Hennes & Mauritz AB Equal Weight | Barclays Capital | |
| 30.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.06.25 | Novo Nordisk Buy | UBS AG | |
| 27.06.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
| 27.06.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 26.06.25 | Hennes & Mauritz AB Neutral | UBS AG | |
| 26.06.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
| 26.06.25 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
| 26.06.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 26.06.25 | Volvo AB Buy | Goldman Sachs Group Inc. | |
| 26.06.25 | AstraZeneca Outperform | Bernstein Research | |
| 25.06.25 | ABB Sell | Deutsche Bank AG | |
| 25.06.25 | Volvo AB Buy | UBS AG | |
| 24.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.06.25 | Volvo AB Underperform | Bernstein Research | |
| 24.06.25 | Volvo AB Buy | UBS AG | |
| 24.06.25 | Novo Nordisk Buy | UBS AG | |
| 24.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.06.25 | ABB Underperform | Bernstein Research | |
| 23.06.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 23.06.25 | Novo Nordisk Overweight | Barclays Capital | |
| 23.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.06.25 | Novo Nordisk Buy | UBS AG |
HOT STOCKS DER LETZTEN 3 TAGE
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.